Farbod Amiri1, Shehroze Tabassum2, Melika Boroomand-Saboor1, Laya Ohadi1*
1School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2King Edward Medical University, Lahore, Pakistan
*Corresponding author: Ohadi Laya, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Email: [email protected]
Received Date: January 23, 2023
Publication Date: January 31, 2023
Citation: Amiri F, et al. (2023). MonkeyPox and Recommendations for Cancer Patients. Mathews J Emergency Med. 8(1):49.
Copyright: Amiri F, et al. © (2023).
During the world is still challenged by the COVID-19 pandemic, the resurgence of the monkeypox virus has elevated solicitude even if it would create a new threat.
The outbreak of the monkeypox virus in humans which can cause an uncommon zoonotic illness similar to a smallpox-like disease commenced in 1970 [1]. At present, whilst this is being written there are no specific medications for patients with a Monkeypox infection.
Most patients have mild disease and heal without therapeutic intervention, but antivirals or vaccinia immune globulin may be used for treating critically ill or immunocompromised individuals.